Press release
Endometrial Cancer Treatment Market :The greatest challenges in the coming year
Overview-
Endometrial cancer is the malignancy that develops in the layers of the cells that form the endometrium, the lining of the uterus. Women with high blood pressure, diabetes, or breast cancer are at a greater risk of being affected by endometrial cancer. It usually affect women post menopause, and the risk increases above the age of 40. Surgical procedure, chemotherapy, immunotherapy, targeted therapy, and brachytherapy are the treatment method of Endometrial Cancer. The global Endometrial Cancer Treatment Market is estimated to value over US$ 12.4 billion by 2027.
Drivers-
Endometrial cancer is one of the most prominently observed cancers in women. According to Cancer Organisation, Cancer is among the leading causes of death worldwide. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide. This leads to the growth of the Endometrial Cancer Treatment Market. In addition, new drug development and commercialization further contribute to the growth of this market.
Request for Exclusive sample report here https://www.worldwidemarketreports.com/sample/476543
Restraints-
Treatment of Endometrial Cancer is expensive. This restricts the growth of the Endometrial Cancer Treatment Market
Regional Insights-
North America is expected to dominate the global endometrial cancer market. This can be majorly attributed to increasing prevalence rates of endometrial cancers. For instance, according to Centers for Disease Control and Prevention, in 2017, there were an estimated 793,846 women living with uterine cancer in the United States. In addition, rising awareness for the diagnosis of cancer and the presence of the developed healthcare infrastructure are expected to propel the market in this region.
Competitive Section-
Some of the major players of the market are Bristol-Myers Squibb Company, Pfizer Inc., R-Pharm-US LLC, Elekta AB, and Varian Medical Systems, Inc.
In May 2017, Merck&Co. Inc. received approval from the US FDA for pembrolizumab, to treat tumors with specific genetic diseases including endometrial cancer
In August 2018, Merck&Co. Inc collaborated with Eisai Co. and received approval from the US FDA to combine Lenvatinib for the treatment of patients with Endometrial Cancer
If you have any questions on this report, please reach out to us @ https://www.worldwidemarketreports.com/quiry/476543
Contact Us:
Mr. Shah
Worldwide Market Reports
Seattle, WA 98154,
U.S.
Email: sales@worldwidemarketreports.com
Worldwide Market Reports provides customized upon request. This report can be personalized to suit your needs. Please contact the research team to ensure you receive the report that fits your needs.
Endometrial cancer is the malignancy that develops in the layers of the cells that form the endometrium, the lining of the uterus. Women with high blood pressure, diabetes, or breast cancer are at a greater risk of being affected by endometrial cancer. It usually affect women post menopause, and the risk increases above the age of 40. Surgical procedure, chemotherapy, immunotherapy, targeted therapy, and brachytherapy are the treatment method of Endometrial Cancer. The global Endometrial Cancer Treatment Market is estimated to value over US$ 12.4 billion by 2027.
Drivers-
Endometrial cancer is one of the most prominently observed cancers in women. According to Cancer Organisation, Cancer is among the leading causes of death worldwide. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide. This leads to the growth of the Endometrial Cancer Treatment Market. In addition, new drug development and commercialization further contribute to the growth of this market.
Request for Exclusive sample report here https://www.worldwidemarketreports.com/sample/476543
Restraints-
Treatment of Endometrial Cancer is expensive. This restricts the growth of the Endometrial Cancer Treatment Market
Regional Insights-
North America is expected to dominate the global endometrial cancer market. This can be majorly attributed to increasing prevalence rates of endometrial cancers. For instance, according to Centers for Disease Control and Prevention, in 2017, there were an estimated 793,846 women living with uterine cancer in the United States. In addition, rising awareness for the diagnosis of cancer and the presence of the developed healthcare infrastructure are expected to propel the market in this region.
Competitive Section-
Some of the major players of the market are Bristol-Myers Squibb Company, Pfizer Inc., R-Pharm-US LLC, Elekta AB, and Varian Medical Systems, Inc.
In May 2017, Merck&Co. Inc. received approval from the US FDA for pembrolizumab, to treat tumors with specific genetic diseases including endometrial cancer
In August 2018, Merck&Co. Inc collaborated with Eisai Co. and received approval from the US FDA to combine Lenvatinib for the treatment of patients with Endometrial Cancer
If you have any questions on this report, please reach out to us @ https://www.worldwidemarketreports.com/quiry/476543
Contact Us:
Mr. Shah
Worldwide Market Reports
Seattle, WA 98154,
U.S.
Email: sales@worldwidemarketreports.com
Worldwide Market Reports provides customized upon request. This report can be personalized to suit your needs. Please contact the research team to ensure you receive the report that fits your needs.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
